The CNTNAP2 gene was identified as a fragile site, and although fragile sites are not traditional mutational targets in cancer, they do exhibit loss of expression in multiple tumor types, suggesting that they may also function as tumor suppressors [23]. This evidence concerns the gene CNTNAP2 and neoplasm.